1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

24 Feb 2024
Admin
News Article

Eisai Gains Approval in Japan for Fycompa

Ligand Partner Eisai Receives Approval in Japan for Injection Formulation of Antiepileptic Drug Fycompa®

Ligand Pharmaceuticals Inc has announced that Eisai Co., Ltd., its partner, has received approval for the injection formulation of their antiepileptic drug (AED) Fycompa® (perampanel) from the Japanese Ministry of Health, Labour and Welfare. This approval, granted in January 2024, allows Fycompa to be used as an alternative therapy in cases where oral administration is temporarily not feasible. Fycompa, incorporating Ligand's Captisol® technology, is a groundbreaking AED discovered at Eisai’s Tsukuba Research Laboratories. It functions as a highly selective, noncompetitive AMPA receptor antagonist, targeting glutamate activity to reduce neuronal hyper-excitation associated with seizures.

Praises from partner

Ligand, emphasized the importance of uninterrupted epilepsy treatment and praised Eisai for enabling this through the new formulation of Fycompa.
Under the partnership agreement established in 2017, Ligand is set to receive royalties from the sales of intravenous Fycompa.

About Perampanel

Perampanel, the active ingredient in Fycompa, is a first-in-class AED developed by Eisai. It acts by selectively inhibiting AMPA receptors, thereby mitigating neuronal hyperexcitation linked to seizures.
Perampanel is approved in numerous countries for adjunctive treatment of partial-onset seizures and primary generalized tonic-clonic seizures in patients aged 12 and older, with varying approval ages across regions.

About Technology : Captisol

Captisol®, the technology utilized in Fycompa's formulation, is a patented cyclodextrin designed to enhance drug solubility and stability.
Developed by scientists at the University of Kansas, Captisol has facilitated the development of several FDA-approved products and is utilized in over 40 partnered programs.

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!